Technical Analysis for VXRT - Vaxart, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.71 | 7.79% | 0.05 |
VXRT closed up 7.79 percent on Friday, April 26, 2024, on 76 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 2
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 7.79% | |
| Down 3 Days in a Row | Weakness | 7.79% | |
| Oversold Stochastic | Weakness | 7.79% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Reversal New Lows Setup | Bearish Swing Setup | -4.79% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 13 hours ago |
| 60 Minute Opening Range Breakdown | about 16 hours ago |
| Gap Up Partially Closed | about 17 hours ago |
| Gapped Up (Partial) | about 18 hours ago |
| Up 5% | about 18 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Vaccines Influenza Coronavirus Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Vaccine Preventable Diseases Human Papilloma Virus Human Papillomavirus Infection
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Vaccines Influenza Coronavirus Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Vaccine Preventable Diseases Human Papilloma Virus Human Papillomavirus Infection
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.59 |
| 52 Week Low | 0.53 |
| Average Volume | 1,725,371 |
| 200-Day Moving Average | 0.85 |
| 50-Day Moving Average | 1.11 |
| 20-Day Moving Average | 0.95 |
| 10-Day Moving Average | 0.79 |
| Average True Range | 0.09 |
| RSI (14) | 26.47 |
| ADX | 36.97 |
| +DI | 7.32 |
| -DI | 32.25 |
| Chandelier Exit (Long, 3 ATRs) | 1.15 |
| Chandelier Exit (Short, 3 ATRs) | 0.89 |
| Upper Bollinger Bands | 1.32 |
| Lower Bollinger Band | 0.57 |
| Percent B (%b) | 0.19 |
| BandWidth | 79.75 |
| MACD Line | -0.12 |
| MACD Signal Line | -0.10 |
| MACD Histogram | -0.0267 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.78 | ||||
| Resistance 3 (R3) | 0.78 | 0.74 | 0.77 | ||
| Resistance 2 (R2) | 0.74 | 0.72 | 0.75 | 0.77 | |
| Resistance 1 (R1) | 0.73 | 0.71 | 0.73 | 0.73 | 0.76 |
| Pivot Point | 0.69 | 0.69 | 0.70 | 0.70 | 0.69 |
| Support 1 (S1) | 0.68 | 0.67 | 0.69 | 0.69 | 0.66 |
| Support 2 (S2) | 0.64 | 0.66 | 0.65 | 0.65 | |
| Support 3 (S3) | 0.63 | 0.64 | 0.65 | ||
| Support 4 (S4) | 0.64 |
